Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Our
History
What is our
Raison d'être
HTL Biotechnology’s mission is to unleash the potential of hyaluronic acid and biopolymers for the benefit of those seeking to improve the health and well-being of millions of patients worldwide.
1977
Foundation of Javenech, a biotechnology research lab committed to human health
1992
Foundation of HTL Biotechnology
1992-2006
Pioneer in Hyaluronic Acid production by bacterial fermentation
2007-2016
HTL Biotechnology becomes the world leader in injectable grade Hyaluronic Acid
2017
Investments in large R&D and production projects
2019
Fermentation-based production of new biopolymers of medical interest
2021
Opening of the new GMP manufacturing facility HTL4
Opening of US and Asia offices
First strategic partnership on functionalization
2023
New GMP chemistry facility to functionalized Biopolymers
A leader for
30 years
The HTL Biotechnology of the future means :
- the constant creation of new and innovative products thanks to our R&D investments. Our ambition is to continue shaping the future of medicine and the biopolymer market,
- an ever-increasing number of applications for our biopolymers,
- a global expansion, from the United States to Asia, while strengthening our teams in France.
Our Values
Excellence
From product sourcing to partnerships of excellence, we do our very best to guarantee the best service to our customers and partners.
Responsibilty
We reliably supply our customers with high-quality, tailor-made products and solutions that perfectly meet their requirements.
Team Spirit
For more than 30 years, we have been developing a relationship of trust, hand-to-hand working with each and every one of our customers to provide a personalized approach to their needs.
Pioneering
Today, all over the world, we continue to co-create with our customers and partners innovative, high-performing solutions to meet unmet medical needs, thanks to our biopolymers platform.
